Geneva Bioinformatics (GeneBio) will distribute Protagen's Modiro, a novel software tool enabling rapid and automated detection of true post-translational modifications in MS/MS datasets
Under the terms of the agreement, GeneBio will distribute the Modiro package on a global basis; at the same time, GeneBio and Protagen will collaborate closely in order to seamlessly link the Modiro functionalities to GeneBio's Phenyx software platform for MS data analysis.
Post-translational protein modifications modulate the activity of many proteins and the in-depth analysis of these changes is of growing importance in the research and development of new drug candidates.
Modiro enables researchers to identify significantly more of these crucial modifications using existing mass-spectrometry data.
In addition, the automated identification of PTMs by Modiro significantly reduces time and efforts in protein analyses.
Developed in collaboration with the Swiss Institute of Bioinformatics (SIB), Phenyx is GeneBio's renowned software platform for the identification and characterization of proteins and peptides from mass spectrometry data.
The Phenyx platform is specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment via a customisable architecture and an innovative user friendly interface.
"We are very excited about this collaboration with GeneBio and believe it will help to bring Modiro to wide range of new customers," said Christoph Huls, CEO of Protagen.
"We are well aware of the reputation of both GeneBio and Phenyx within the industry and feel that our combined efforts will help to establish Modiro as the gold-standard for PTM analysis.
"In addition, we look forward to working with the GeneBio team in order to enhance both the Modiro and Phenyx platform".
"We are pleased to be able to distribute Modiro and work with Protagen to help raise the bar in our industry," said Nasri Nahas, CEO of GeneBio.
"The addition of Modiro to our product line-up and the eventual technological gains that our companies will share through this cooperation will bring us closer to our goal of providing the most comprehensive platform in the MS field.
"Phenyx has seen significant traction in the market since its inception; working with Protagen will build and extend our expertise, thereby bringing us closer to our goals."
